A recent study investigates the hippocampal delivery of the NF-α1/CPE gene via AAV vectors in an AD mouse model, notably decreasing amyloid precursor protein (APP) expression, levels of insoluble Aβ1-42, and tau hyperphosphorylation, critical markers of AD. This evidence concerns the gene MAPT and Alzheimer disease.